Danone has recently expanded its line of products for adults with special medical needs in China with the addition of the Fortimel brand to its existing portfolio of Nutrison and Peptisorb tube-feeding products in the country.
The reason for adding Fortimel is to respond to the country’s growing ageing population and the rising ‘incidence of chronic disease’ as well as ‘rising demand for ‘adequate nutritional care upon discharge’ from hospital.
The drinks are designed to meet the nutritional needs of patients recovering after surgery or non-communicable diseases like cancer and stroke.
Bruno Chevot, President of Danone’s business in China, North Asia and Oceania said, “It marks a solid step into the AFSMP [Adult Foods for Special Medical Purposes] market in China and helps Danone to further grow its portfolio covering the full life spectrum.”
Danone’s medical nutrition business is part of its wider Specialised Nutrition division, which also includes products for infants like baby food and formula. The company claimed that its medical nutrition products accounted for approximately 40% of the division’s sales. Overall, the business unit accounts for 30% of Danone’s total revenue.